AI and Autonomy Coreline Soft provides AI software to French lung cancer screening initiative The South Korean company is now the exclusive supplier for the government-led program Rowan Dunne53 minutes ago
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph Morton23 hours ago
Medical and Pharmaceutical Prenetics Global shares spike on significant revenue developments The company projects 2025 revenue to range between USD$73 million and USD$85 million Joseph Morton6 days ago
Health & Wellness ‘Give a Breath’ 5K run raises lung cancer awareness in Canadian cities next month Ottawa and Calgary are new participants this year Rowan Dunne6 days ago
Medical and Pharmaceutical Researcher wants to know if supplement can lessen risk of radon-linked lung cancer Him and his team have C$1.7M at their disposal for the next few years to find out Rowan DunneMay 21, 2025
Medical and Pharmaceutical BioMark Diagnostics reveals AI breakthrough in early lung cancer detection The model uses graph neural networks to interpret complex biological interactions Joseph MortonMay 20, 2025
Medical and Pharmaceutical Alberta invests C$2M for continuation of provincial lung cancer screening program The Alberta Cancer Foundation is also contributing C$500K Rowan DunneMay 20, 2025
AI and Autonomy Canadian healthcare just got a little more organized with Oracle AI Oracle's agent combines generative AI, agentic technology, automation, multimodal voice, and screen-driven assistance into one solution Joseph MortonMay 15, 2025
Medical and Pharmaceutical Breath tests could soon become key diagnosis tool for multiple diseases Researchers are working to bring this technology to market Joseph MortonMay 14, 2025
Medical and Pharmaceutical International lung cancer screening market poised for steady growth: 2025 report It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says Rowan DunneMay 9, 2025